Re: Two centres' experience with lung cancer resection in patients with advanced non-small-cell lung cancer following treatment with immune checkpoint inhibitors: safety and clinical outcomes

被引：3

作者：

Mennecier, Bertrand ^{[1
]}

Olland, Anne ^{[2
,3
,4
]}

Mascaux, Celine ^{[1
,5
]}

Falcoz, Pierre-Emmanuel ^{[2
,3
,4
]}

机构：

[1] Strasbourg Univ Hosp, Dept Pneumol, Strasbourg, France

[2] INSERM French Natl Inst Hlth & Med Res, UMR 1260, Regenerat Nanomed RNM, FMTS, Strasbourg, France

[3] Univ Strasbourg, Fac Med & Pharm, Strasbourg, France

[4] Hop Univ Strasbourg, Nouvel Hop Civil, Serv Chirurg Thorac, Strasbourg, France

[5] Univ Strasbourg, IRFAC, Lab Streinth STress REsponse & INnovat THerapy Ca, Inserm UMR S 1113,ITI InnoVec, Strasbourg, France

来源：

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY | 2021年 / 60卷 / 06期

关键词：

Lung cancer; Surgical therapy; Combined treatment modalities; Immunotherapy; IMMUNOTHERAPY;

D O I：

10.1093/ejcts/ezab399

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1306 / 1307

页数：2

共 8 条

[1] Two centres experience of lung cancer resection in patients with advanced non-small cell lung cancer upon treatment with immune checkpoint inhibitors: safety and clinical outcomes [J].

Beattie, Rory ;

Furrer, Katarzyna ;

Dolan, Daniel P. ;

Curioni-Fontecedro, Alessandra ;

Lee, Daniel N. ;

Frauenfelder, Thomas ;

Hoeller, Sylvia ;

Weder, Walter ;

Bueno, Raphael ;

Opitz, Isabelle ;

Swanson, Scott .

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2021, 60 (06) :1297-1305

[2] Phase II Trial of Neoadjuvant Bevacizumab Plus Chemotherapy and Adjuvant Bevacizumab in Patients with Resectable Nonsquamous Non-Small-Cell Lung Cancers [J].

Chaft, Jamie E. ;

Rusch, Valerie ;

Ginsberg, Michelle S. ;

Paik, Paul K. ;

Finley, David J. ;

Kris, Mark G. ;

Price, Katharine A. R. ;

Azzoli, Christopher G. ;

Fury, Matthew G. ;

Riely, Gregory J. ;

Krug, Lee M. ;

Downey, Robert J. ;

Bains, Manjit S. ;

Sima, Camelia S. ;

Rizk, Nabil ;

Travis, William D. ;

Rizvi, Naiyer A. .

JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (08) :1084-1090

[3] Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer [J].

Liang, Wenhua ;

Cai, Kaican ;

Chen, Chun ;

Chen, Haiquan ;

Chen, Qixun ;

Fu, Junke ;

Hu, Jian ;

Jiang, Tao ;

Jiao, Wenjie ;

Li, Shuben ;

Liu, Changhong ;

Liu, Deruo ;

Liu, Wei ;

Liu, Yang ;

Ma, Haitao ;

Pan, Xiaojie ;

Qiao, Guibin ;

Tian, Hui ;

Wei, Li ;

Zhang, Yi ;

Zhao, Song ;

Zhao, Xiaojing ;

Zhou, Chengzhi ;

Zhu, Yuming ;

Zhong, Ran ;

Li, Feng ;

Rosell, Rafael ;

Provencio, Mariano ;

Massarelli, Erminia ;

Antonoff, Mara B. ;

Hida, Toyoaki ;

de Perrot, Marc ;

Lin, Steven H. ;

Di Maio, Massimo ;

Rossi, Antonio ;

De Ruysscher, Dirk ;

Ramirez, Robert A. ;

Dempke, Wolfram C. M. ;

Camidge, D. Ross ;

Guibert, Nicolas ;

Califano, Raffaele ;

Wang, Qi ;

Ren, Shengxiang ;

Zhou, Caicun ;

He, Jianxing .

TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (06) :2696-+

[4] Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease [J].

Liu, Jing ;

Blake, Stephen J. ;

Yong, Michelle C. R. ;

Harjunpaa, Heidi ;

Ngiow, Shin Foong ;

Takeda, Kazuyoshi ;

Young, Arabella ;

O'Donnell, Jake S. ;

Allen, Stacey ;

Smyth, Mark J. ;

Teng, Michele W. L. .

CANCER DISCOVERY, 2016, 6 (12) :1382-1399

[5] Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) plus platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC). [J].

Spicer, Jonathan ;

Wang, Changli ;

Tanaka, Fumihiro ;

Saylors, Gene Brian ;

Chen, Ke-Neng ;

Liberman, Moishe ;

Vokes, Everett E. ;

Girard, Nicolas ;

Lu, Shun ;

Provencio, Mariano ;

Mitsudomi, Tetsuya ;

Awad, Mark M. ;

Felip, Enriqueta ;

Forde, Patrick M. ;

Swanson, Scott ;

Brahmer, Julie R. ;

Kerr, Keith ;

Dorange, Cecile ;

Cai, Junliang ;

Broderick, Stephen .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

[6] Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancer [J].

Tong, Betty C. ;

Gu, Lin ;

Wang, Xiaofei ;

Wigle, Dennis A. ;

Phillips, Joseph D. ;

Harpole Jr, David H. ;

Klapper, Jacob A. ;

Sporn, Thomas ;

Ready, Neal E. ;

D'Amico, Thomas A. .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 163 (02) :427-436

[7] IMpower010: Primary results of a phase III global study of atezolizumab versus best supportive care after adjuvant chemotherapy in resected stage IB-IIIA non-small cell lung cancer (NSCLC). [J].

Wakelee, Heather A. ;

Altorki, Nasser K. ;

Zhou, Caicun ;

Csoszi, Tibor ;

Vynnychenko, Ihor O. ;

Goloborodko, Oleksandr ;

Luft, Alexander ;

Akopov, Andrey ;

Martinez-Marti, Alex ;

Kenmotsu, Hirotsugu ;

Chen, Yuh-Min ;

Chella, Antonio ;

Sugawara, Shunichi ;

Gitlitz, Barbara J. ;

Bennett, Elizabeth ;

Wu, Fan ;

Yi, Jing ;

Deng, Yu ;

McCleland, Mark ;

Felip, Enriqueta .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

[8] Neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC): Preliminary results from a multicenter study (IFCT-1601 IONESCO) [J].

Wislez, M. ;

Mazieres, J. ;

Lavole, A. ;

Zalcman, G. ;

Carre, O. ;

Egenod, T. ;

Caliandro, R. ;

Gervais, R. ;

Jeannin, G. ;

Molinier, O. ;

Massiani, M. A. ;

Langlais, A. ;

Morin, F. ;

Barthes, F. Le Pimpec ;

Brouchet, L. ;

Assouad, J. ;

Milleron, B. ;

Damotte, D. ;

Antoine, M. ;

Westeel, V. .

ANNALS OF ONCOLOGY, 2020, 31 :S794-S794

← 1 →